Category: Public Health/Global Health
Poster Session IV
To evaluate trends in sociodemographic factors (SDFs) associated with the surge in gonorrhea (GC) infections in pregnancy during the COVID-19 pandemic in the United States (US).
Study Design: Retrospective analysis of the US Centers for Disease Control and Prevention Natality Live Birth database (2016-2020). The study group included all births between 4/1/2020 and 12/31/20 (i.e. pandemic group), whereas births between 1/1/16 and 2/29/20 comprised the comparison group (i.e. pre-pandemic group). We compared the prevalence of GC in pregnancy stratified by multiple maternal SDFs between the two groups. Statistical analysis included use of Chi-squared test with significance set at P < 0.05.
Results: Of the total 18,648,594 births, 2,719,573 (14.6%) were in the pandemic group. The prevalence of GC in pregnancy during the pandemic increased by 17% compared to the pre-pandemic period (9,430/2,719,573 [0.35%] vs. 47,611/15,929,021 [0.30%], P = < 0.001). The SDFs associated with the highest prevalence of GC in both groups were concurrent sexually transmitted infections, tobacco use, age < 20 years old, low education level, Medicaid insurance, late to prenatal care, and non-Hispanic black race (Table). Nevertheless, the highest increase in the prevalence of GC during the pandemic was seen in “low-risk groups” such as older maternal age (30% increase in > 40 years old), college graduates (24% increase), and patients with private insurance (26% increase) (Table).
Conclusion: The prevalence of GC during pregnancy increased in the US during the COVID-19 pandemic among all SDFs evaluated. Moreover, although the SDFs associated with the highest prevalence of GC were the same in both groups, we identified that low-risk groups (i.e. older age, higher education level, and private insurance) had the steepest increase in risk of infection during the COVID-19 pandemic. These data suggest that GC prevalence among various sociodemographic groups was disproportionately affected by the COVID-19 pandemic.
Moti Gulersen, MD,MSc
Assistant Professor, Obstetrics and Gynecology
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Erez Lenchner, PhD
Biostatistics and Data Management
New York University Rory Meyers College of Nursing
New York, New York, United States
Amos Grunebaum, MD
Zucker School of Medicine at Hofstra and Northwell, Department of OBGYN, Lenox Hill Hospital
New York, New York, United States
Frank A. Chervenak, MD
Zucker School of Medicine at Hofstra and Northwell
Hempstead, New York, United States
Eran Bornstein, MD
Vice Chair of Obstetrics
Zucker School of Medicine at Hofstra and Northwell
Manhasset, New York, United States